A Clinical trial to study the effect of Siddha medicine Kirambu Chooranam in patients having Karasthamba vatham (peripheral neuritis)

Phase II non-randomized open clinical evaluation of Siddha medicine Kirambu Chooranam for Karasthamba vatham (peripheral neuritis)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/10/028655

Enrollment

Registered

2020-10-27

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G64- Other disorders of peripheral nervous system

Interventions

Intervention1: KIRAMBU CHOORANAM: 1-2 grams of kirambu chooranam is administrated thrice a day with luke warm water for 48 days Intervention2: Kirambu chooranam: 1-2 grams of kirambu chooranam is adm

Eligibility

Inclusion criteria

Inclusion criteria: Both gender of Type 2 Diabetic patients who having complaints like tingling and numbness of feet and hands, burning sensation in sole of feet, heat intolerance (unilateral/ bilateral)

Exclusion criteria

Exclusion criteria: Patients with known history of hyperthyroidism/ hypothyroidism, drug induced neuropathy, nutritional deficiency neuropathy, renal caused neuropathy

Design outcomes

Primary

Measure	Time frame
Primary outcome is mainly assessed by diabetic control level and management of numbness and burning sensationTimepoint: 48 days	—

Secondary

Measure	Time frame
Secondary outcome is assessed by comparing the safety parameters before and after treatmentTimepoint: 48 Days	—

Countries

India

Contacts

Public ContactDr Parwin L

Government Siddha Medical College

nanbu.sumi@gmail.com9443279412

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026